Linical
Aiko Kawabata is a seasoned professional in pharmacovigilance with extensive experience at Linical as a Pharmacovigilance Associate since October 2019 and previously at EPS as a Pharmacovigilance Officer from November 2012 to October 2019. Aiko's career started in the hospitality industry, working as hotel staff at The Ritz-Carlton, Osaka, from April 2008 to June 2009. Aiko holds a Bachelor's degree in Liberal Arts with a focus on Informatics from The Open University of Japan, completed between 2015 and 2020, and has pursued additional education at the University of the People since 2018, alongside attending the ILC International Language Center from 2011 to 2012 and the Hospitality and Tourism College Osaka from 2006 to 2008.
This person is not in the org chart
Linical
Linical is a global Contract Research Organization (CRO) for full-service drug development, with a proven record of helping biopharmaceutical companies successfully navigate the clinical development journey. Linical is headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides a full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases. Combining strong business perspective with clinical and medical expertise, our team goes beyond operational excellence providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. We strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.